Cargando…

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?

Aims. To evaluate whether reduced waiting time influences survival of patients treated with whole-brain radiotherapy (WBRT) for brain metastases. Materials and Methods. Retrospective intention-to-treat study including 110 patients treated with primary WBRT (typically 10 fractions of 3 Gy; no other t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieder, Carsten, Spanne, Oddvar, Haukland, Ellinor, Dalhaug, Astrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649498/ https://www.ncbi.nlm.nih.gov/pubmed/23691360 http://dx.doi.org/10.1155/2013/214304

Ejemplares similares

The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2021)

Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
por: Angelo, Kent, et al.
Publicado: (2014)

Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
por: Nieder, Carsten, et al.
Publicado: (2012)

Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Palliative Radiotherapy with or without Additional Care by a Multidisciplinary Palliative Care Team: A Retrospective Comparison
por: Nieder, Carsten, et al.
Publicado: (2014)

The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
por: Nieder, Carsten, et al.
Publicado: (2023)

Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases
por: Nieder, Carsten, et al.
Publicado: (2010)

Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
por: Nieder, Carsten, et al.
Publicado: (2020)

Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?
por: Nieder, Carsten, et al.
Publicado: (2019)

Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison
por: Nieder, Carsten, et al.
Publicado: (2015)

Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)
por: Dalhaug, Astrid, et al.
Publicado: (2010)

Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
por: Nieder, Carsten, et al.
Publicado: (2012)

Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance
por: Nieder, Carsten, et al.
Publicado: (2017)

Palliative Thoracic Radiotherapy for Non-Small Cell Lung Cancer in Outpatients: Reasons for Unplanned Hospitalization and Its Impact on Survival
por: Nieder, Carsten, et al.
Publicado: (2021)

Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
por: Nieder, Carsten, et al.
Publicado: (2022)

External Validation of the LabBM Score in Patients With Brain Metastases
por: Nieder, Carsten, et al.
Publicado: (2019)

Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
por: Nieder, Carsten, et al.
Publicado: (2022)

Contribution of Case Reports to Brain Metastases Research: Systematic Review and Analysis of Pattern of Citation
por: Nieder, Carsten, et al.
Publicado: (2012)

30-day mortality in patients treated for brain metastases: extracranial causes dominate
por: Nieder, Carsten, et al.
Publicado: (2022)

Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
por: Nieder, Carsten, et al.
Publicado: (2014)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case report
por: Dalhaug, Astrid, et al.
Publicado: (2008)

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2012)

Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?
por: Nieder, Carsten, et al.
Publicado: (2008)

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Presentation and outcome in cancer patients with extensive spread to the brain
por: Nieder, Carsten, et al.
Publicado: (2009)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram?
por: Nieder, Carsten, et al.
Publicado: (2017)

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
por: Fogarty, Gerald, et al.
Publicado: (2011)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
por: Frisk, Gabriella, et al.
Publicado: (2017)

Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer
por: Okada, Yukinori, et al.
Publicado: (2020)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
por: Zindler, Jaap D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8jph705mtk2oearrb4n9jkuki7